Antiphospholipid (APL) syndrome is the most common form of acquired thrombophilia. It can
cause significant morbidity and even mortality. The term “APL antibodies” represents a …

Antiphospholipid syndrome (APLS) is a complex systemic disease with a wide variety of
clinical manifestations. In the obstetric population, recurrent early pregnancy loss, fetal loss …

Vascular thrombosis and pregnancy morbidity represent the clinical manifestations of
antiphospholipid syndrome (APS), which is serologically characterized by the persistent …

The presence of antiphospholipid antibodies (aPL) combined with venous or arterial
thrombosis, and/or obstetric complications defines the antiphospholipid syndrome (APS) …

Antiphospholipid syndrome (APS) is an acquired thrombophilia with clinical manifestations
associated with the presence of antiphospholipid antibodies (aPL) in patient plasma …

The antiphospholipid syndrome (APS) is characterized by thrombosis or pregnancy
morbidity in the presence of antiphospholipid autoantibodies (aPL). aPL are a …

Antiphospholipid antibodies (aPL) are an heterogeneous group of circulating
immunoglobulins arising in a wide range of infectious and autoimmune diseases. Since the …

Antiphospholipid syndrome (APS) is an autoimmune disorder in which autoantibody
production can lead to a hypercoagulable state, pregnancy failure and/or a multitude of …

Persistently positive antiphospholipid antibodies (aPL) with thrombosis and/or pregnancy
morbidity are a characteristic of antiphospholipid syndrome (APS). Although many …

Antiphospholipid syndrome (APS) is an autoimmune disorder in which autoantibody
production may lead to a hypercoagulable state, pregnancy failure and/or a multitude of …